Abstract: An electric power steering apparatus includes a rotating assist force computing unit for computing an assist force in the rotating direction of a steering wheel, a returning assist force computing unit for computing a returning assist force, which is a steering assist force in a direction opposite to the rotating direction, and a summing unit for adding up the computed assist force in the rotating direction and the computed returning assist force. The electric power steering apparatus returns the steering wheel and steered road wheels to the neutral position at an earlier time if a driver releases his or her hands from the steering wheel when rotating the steering wheel.

Abstract: An electric power steering apparatus includes a rotating assist force computing unit for computing an assist force in the rotating direction of a steering wheel, a returning assist force computing unit for computing a returning assist force, which is a steering assist force in a direction opposite to the rotating direction, and a summing unit for adding up the computed assist force in the rotating direction and the computed returning assist force. The electric power steering apparatus returns the steering wheel and steered road wheels to the neutral position at an earlier time if a driver releases his or her hands from the steering wheel when rotating the steering wheel.

Abstract: Provided is a package of a solid pharmaceutical preparation capable of preventing an unpleasant odor and coloring due to hydrolysis progressing during storage of a solid pharmaceutical preparation containing 1-{[(?-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid. A package of a solid pharmaceutical preparation housing a solid pharmaceutical preparation containing 1-{[(?-isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid includes a PTP package, an adsorbent, and an outer packaging material. The PTP package includes the solid pharmaceutical preparation, a container sheet for housing the solid pharmaceutical preparation, and a cover sheet having gas permeability sealing the solid pharmaceutical preparation. The adsorbent includes at least zeolite. The outer packaging material includes a gastight material to house and seal the adsorbent and the PTP package.

Abstract: The present invention relates to the provision of a stable particulate pharmaceutical composition of solifenacin or a salt thereof, which is in a spherical shape suitable for coating and in which degradation with time can be inhibited when a pharmaceutical preparation of solifenacin or a salt thereof is supplied to clinical fields. More particularly, it relates to a particulate pharmaceutical composition that can be obtained by using a binder having a Tg or mp lower than 174C upon formulating a particulate composition of solifenacin into a pharmaceutical preparation. Further, by performing a crystallization-promoting treatment after the particulate pharmaceutical composition is produced, a more stable particulate composition of solifenacin or a salt thereof can be provided.

Abstract: The present invention provides a method for removing unsaturated uronic acid contained in chemical pulp for papermaking, characterized by adding glucuronidase. According to the preferred embodiment of the present invention, in an ECF or TCF bleaching method using no molecular chlorine, unsaturated uronic acid can be reduced while controlling a bleaching cost, and a brightness reversion property of pulp can be improved.

Abstract: The present invention makes it possible to provide drug-containing coated microparticles for quick-disintegrating oral tablets wherein microparticles containing a drug with an unpleasant taste are coated with a film composed of (1) a pH-independent water-insoluble polymer accounting for 60% or more but less than 80% of the film and (2) a pH-independent water-soluble substance accounting for more than 20% to 40% or less of the film, these microparticles being characterized in that the rate of dissolution of the drug from the drug-containing microparticles is 0% to 10% in one minute and 80% to 100% in 30 minutes, and the average particle diameter is 350 ?m or less, in order to realize sufficient control of oral drug dissolution and fast gastrointestinal drug dissolution.